Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Operating Expenses (2016 - 2025)

AtriCure (ATRC) has disclosed Operating Expenses for 16 consecutive years, with $102.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 4.01% to $102.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $410.2 million, a 5.85% increase, with the full-year FY2025 number at $410.2 million, up 5.85% from a year prior.
  • Operating Expenses was $102.8 million for Q4 2025 at AtriCure, up from $101.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $107.7 million in Q2 2025 to a low of -$46.4 million in Q3 2021.
  • A 5-year average of $78.2 million and a median of $81.6 million in 2023 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: plummeted 204.78% in 2021, then skyrocketed 255.97% in 2022.
  • AtriCure's Operating Expenses stood at $67.5 million in 2021, then increased by 2.56% to $69.2 million in 2022, then rose by 27.78% to $88.5 million in 2023, then rose by 21.09% to $107.1 million in 2024, then decreased by 4.01% to $102.8 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Operating Expenses are $102.8 million (Q4 2025), $101.1 million (Q3 2025), and $107.7 million (Q2 2025).